Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human anti-mouse antibodies.

G G Klee1

  • 1Department of Laboratory Medicine and Pathology, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA.

Archives of Pathology & Laboratory Medicine
|June 3, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Plasma islet amyloid polypeptide is not an effective tumor marker for pancreatic cancer even when protease inhibitors and rapid freezing of specimens are utilized.

Clinical chemistry·2001
Same author

Islet amyloid polypeptide is not a satisfactory marker for detecting pancreatic cancer.

Gastroenterology·2001
Same author

Neuropeptide Y, leptin, and cholecystokinin 8 in patients with advanced cancer and anorexia: a North Central Cancer Treatment Group exploratory investigation.

Cancer·2001
Same author

Development of a dual monoclonal antibody immunoassay for total human kallikrein 2.

Clinical chemistry·2001
Same author

Prolonged inhibition of presynaptic catecholamine synthesis with alpha-methyl-para-tyrosine attenuates the circadian rhythm of human TSH secretion.

Journal of the Society for Gynecologic Investigation·2001
Same author

An evaluation of analytic goals for assays of drugs: a College of American Pathologists Therapeutic Drug Monitoring Survey Study.

Archives of pathology & laboratory medicine·2001
Same journal

Assessing Human Epidermal Growth Factor Receptor 2 in Urothelial Carcinoma: Insights From Clinical Practice Into Scoring Criteria, Histologic Subtypes, and Genomic Characteristics Across Disease Sites.

Archives of pathology & laboratory medicine·2026
Same journal

Cross-Reactivity of TPIT Antibody Clone OTI2G1 in Chordoma: Structural Mechanisms and Diagnostic Implications.

Archives of pathology & laboratory medicine·2026
Same journal

Paracoccidioidomycosis at Autopsy: A Case Series and Literature Review.

Archives of pathology & laboratory medicine·2026
Same journal

Accuracy of Cytology Diagnosis for Well Differentiated Neuroendocrine Tumors: Assessment by the College of American Pathologists Non-Gynecologic Slide Program.

Archives of pathology & laboratory medicine·2026
Same journal

Serum Immunofixation Electrophoresis Guidance Conflict: A Call to Harmonize.

Archives of pathology & laboratory medicine·2026
Same journal

In Reply.

Archives of pathology & laboratory medicine·2026
See all related articles

Human anti-mouse antibodies (HAMA) can form in patients receiving mouse antibody therapies. These HAMA can interfere with diagnostic tests, impacting patient care and research accuracy.

Area of Science:

  • Immunology
  • Biotechnology
  • Clinical Diagnostics

Background:

  • Increasing use of monoclonal mouse antibodies in diagnostics and therapeutics.
  • Human anti-mouse antibodies (HAMA) are human immunoglobulins targeting mouse immunoglobulins.
  • HAMA presence is a growing concern in clinical applications.

Purpose of the Study:

  • To review HAMA production in patients undergoing monoclonal antibody treatment.
  • To illustrate how HAMA can interfere with immunoassay measurements.
  • To discuss methods for HAMA detection and neutralization.

Main Methods:

  • Literature review on HAMA production and impact.
  • Analysis of HAMA interference mechanisms in immunoassays.
  • Overview of current HAMA measurement and neutralization techniques.

Related Experiment Videos

Main Results:

  • HAMA production is a common response to mouse antibody administration.
  • HAMA can cause false positive or negative results in immunoassays.
  • Effective methods for HAMA detection and management exist.

Conclusions:

  • Understanding HAMA is crucial for accurate interpretation of diagnostic tests.
  • Strategies to mitigate HAMA interference are essential for reliable clinical outcomes.
  • Further research into HAMA modulation may improve therapeutic antibody efficacy.